Browse Title Index

Issue Title
Vol 23, No 6 (2016) Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016 Abstract   PDF   HTML
D. Bossé, T. Ng, C. Ahmad, A. Alfakeeh, I. Alruzug, J. Biagi, J. Brierley, P. Chaudhury, S. Cleary, B. Colwell, C. Cripps, L.A. Dawson, M. Dorreen, E. Ferland, P. Galiatsatos, S. Girard, S. Gray, F. Halwani, N. Kopek, A. Mahmud, G. Martel, L. Robillard, B. Samson, M. Seal, J. Siddiqui, L. Sideris, S. Snow, M. Thirwell, M. Vickers, R. Goodwin, R. Goel, T. Hsu, E. Tsvetkova, B. Ward, T. Asmis
Vol 26, No 5 (2019) Eastern Canadian Gastrointestinal Cancer Consensus Conference 2018 Abstract   PDF   HTML
A.J. Hyde, R. Nassabein, A. AlShareef, D. Armstrong, S. Babak, S. Berry, D. Bossé, E. Chen, B. Colwell, C. Essery, R. Goel, R. Goodwin, S. Gray, N. Hammad, A. Jeyakuymar, D. Jonker, P. Karanicolas, N. Lamond, R. Letourneau, J. Michael, N. Patil, E. Powell, R. Ramjeesingh, W. Saliba, R. Singh, S. Snow, T. Stuckless, S. Tadros, M. Tehfé, M. Thana, M. Thirlwell, M. Vickers, K. Virik, S. Welch, T. Asmis
Vol 24, No 1 (2017) Economic evaluation of brentuximab vedotin for persistent Hodgkin lymphoma Abstract   PDF   HTML
V. Babashov, M.A. Begen, J. Mangel, G.S. Zaric
Vol 22, No 2 (2015) Economic evaluation of hormonal therapies for postmenopausal women with estrogen receptor–positive early breast cancer in Canada Abstract   PDF   HTML
S. Djalalov, J. Beca, E. Amir, M. Krahn, M.E. Trudeau, J.S. Hoch
Vol 14, No 2 (2007) Editorial Details   PDF
Mike McLean
Vol 14, No 3 (2007) Editorial Details   PDF
Mike McLean
Vol 14, No 4 (2007) Editorial Details   PDF
Mike McLean
Going Beyond Efficacy Editorial Details   PDF
Sunil Verma
Vol 15, No 3 (2008) Editorial Abstract   PDF
Phil Gold
Vol 15, No 5 (2008) EDITORIAL Abstract   PDF
Richard J. Ablin
Vol 15, No 6 (2008) Editorial Abstract   PDF
Mike McLean
Vol 16, No 1 (2009) Editorial Abstract   PDF
Mike McLean
Vol 16, No 2 (2009) Editorial Abstract   PDF
Mike McLean
Vol 16, No 4 (2009) Editorial Abstract   PDF
Mike McLean
Vol 18, No 2 (2011) Editorial Details   PDF   HTML
M. McLean
Vol 18, No 3 (2011) Editorial Details   PDF   HTML
Mike McLean
Vol 15, No 2 (2008) editorial 2_08 Abstract   PDF
Mike McLean
Vol 13, No 5 (2006) Editorial 5/06 Details   PDF
Michael McLean
Vol 14, No 5 (2007) Editorial 5/07 Details   PDF
Mike McLean
Vol 14, No 6 (2007) Editorial 6/2007 Details   PDF
Mike McLean
Vol 15, No 1 (2008) Editorial for 1/2008 Details   PDF
Mike McLean
Vol 13, No 4 (2006) Editorial4_06 Details   PDF
Michael McLean
Vol 15, No 4 (2008) Editorial: Integrative Oncology and an Integrative Cancer Journal Abstract   PDF
Stephen Sagar
Vol 13, No 3 (2006) Editorial: Volume 13, Number 3 Details   PDF
Michael McLean
Vol 13, No 6 (2006) Editorial: Volume 13, Number 6 Details   PDF
Michael McLean
Vol 20, No 1 (2013) Effect of cancer on ovarian function in patients undergoing in vitro fertilization for fertility preservation: a reappraisal Details   PDF   HTML
I. Levin, B. Almog
Vol 23, No 6 (2016) Effect of chemotherapy on health-related quality of life among early-stage ovarian cancer survivors: a study from the population-based PROFILES registry Abstract   PDF   HTML
C.S. Bhugwandass, J.M.A. Pijnenborg, B. Pijlman, N.P.M. Ezendam
Vol 25, No 1 (2018) Effect of early palliative care on quality of life in patients with non-small-cell lung cancer Abstract   PDF   HTML
H. Zhuang, Y. Ma, L. Wang, H. Zhang
Vol 19, No 3 (2012) Effect of exercise in reducing breast and chest-wall pain in patients with breast cancer: a pilot study Abstract   PDF   HTML
P. Wong, T. Muanza, T. Hijal, L. Masse, S. Pillay, M. Chasen, I. Lowensteyn, M. Gold, S. Grover
Vol 24, No 3 (2017) Effect of non-alcoholic liver disease on recurrence rate and liver regeneration after liver resection for colorectal liver metastases Abstract   PDF   HTML
N.W. Molla, M.M. Hassanain, Z. Fadel, L.M. Boucher, A. Madkhali, R.M. Altahan, E.A. Alrijraji, E.B. Simoneau, H. Alamri, A. Salman, Z. Gao, P.P. Metrakos
Vol 26, No 3 (2019) Effect of obesity, dyslipidemia, and diabetes on trastuzumab-related cardiotoxicity in breast cancer Abstract   PDF   HTML   Supplemental Material
P. Kosalka, C. Johnson, M. Turek, J. Sulpher, A. Law, J. Botros, S. Dent, O. Aseyev
Vol 21, No 3 (2014) Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma—a pilot study Abstract   PDF   HTML
M. Orditura, G. Galizia, N. Di Martino, E. Ancona, C. Castoro, R. Pacelli, F. Morgillo, S. Rossetti, V. Gambardella, A. Farella, M.M. Laterza, A. Ruol, A. Fabozzi, V. Napolitano, F. Iovino, E. Lieto, L. Fei, A. Renda, F. Ciardiello, F. De Vita
Vol 26, No 3 (2019) Effectiveness of first-line treatments in metastatic squamous non-small-cell lung cancer Abstract   PDF   HTML
B. P. Levy, J. E. Signorovitch, H. Yang, O. Patterson-Lomba, C. Q. Xiang, M. Parisi
Vol 21, No 2 (2014) Effects of dna-dependent protein kinase inhibition by NU7026 on dna repair and cell survival in irradiated gastric cancer cell line N87 Abstract   PDF   HTML
M.T. Niazi, G. Mok, M. Heravi, L. Lee, T. Vuong, R. Aloyz, L. Panasci, T. Muanza
Vol 26, No 1 (2019) Effects of magnanimous therapy on coping, adjustment, and living function in advanced lung cancer Abstract   PDF   HTML
X. Huang, A. Yan, Q. Liu, L. Wu
Vol 19, No 4 (2012) Effects of radiation and total androgen blockade on serum hemoglobin, testosterone, and erythropoietin in patients with localized prostate cancer Abstract   PDF   HTML
M. Golfam, R. Samant, L. Eapen, S. Malone
Vol 24, No 5 (2017) Effects of the community-based Wellspring Cancer Exercise Program on functional and psychosocial outcomes in cancer survivors Abstract   PDF   HTML
D. Santa Mina, D. Au, J. Brunet, J. Jones, G. Tomlinson, N. Taback, D. Field, A. Berlingeri, H. Bradley, D. Howell
Vol 23, No 1 (2016) Effects of warm acupuncture on breast cancer–related chronic lymphedema: a randomized controlled trial Abstract   PDF   HTML
C. Yao, Y. Xu, L. Chen, H. Jiang, C.S. Ki, J.S. Byun, W. Bian
Vol 26, No 1 (2019) Efficacy and safety of combined androgen blockade with antiandrogen for advanced prostate cancer Abstract   PDF   HTML
Y. Yang, R. Chen, T. Sun, L. Zhao, F. Liu, S. Ren, H. Wang, X. Lu, X. Gao, C. Xu, Y. Sun
Vol 20, No 4 (2013) Efficacy and tolerability of toremifene and tamoxifen therapy in premenopausal patients with operable breast cancer: a retrospective analysis Abstract   PDF   HTML
T. Qin, Z.Y. Yuan, R.J. Peng, Y.D. Zeng, Y.X. Shi, X.Y. Teng, D.G. Liu, B. Bai, S.S. Wang
Vol 24, No 3 (2017) Efficacy of metronomic vinorelbine in elderly patients with advanced non-small-cell lung cancer and poor performance status Abstract   PDF   HTML
C. Bilir, S. Durak, B. Kızılkaya, I. Hacıbekiroglu, E. Nayır, H. Engin
Vol 26, No 1 (2019) Efficacy of second-line chemotherapy after a first-line triplet in patients with metastatic colorectal cancer Abstract   PDF   HTML
S. Bazarbashi, A. M. Hakoun, A. M. Gad, M. A. Elshenawy, A. Aljubran, A. Alzahrani, A. Eldali
Vol 17 (2010): Optimal management of metastatic colorectal cancer with the anti-EGFR monoclonal antibodies Efficacy of the monoclonal antibody EGFR inhibitors for the treatment of metastatic colorectal cancer Abstract   PDF
M. Fakih, R. Wong
Vol 16, No 5 (2009) Efficacy of third-line therapy using bevacizumab in a patient with metastatic colorectal cancer Details   PDF
J. Gaulin, R. Kotb, E. Turcotte, G. Bérard, G. Schmutz, B. Sawan, P. Beauregard
Vol 17, No 1 (2010) EGFR overexpression in squamous cell carcinoma of the penis Abstract   PDF
N. Lavens, R. Gupta, L.A. Wood
Vol 19, No 1 (2012) EGFR tyrosine kinase inhibitors in lung cancer: make no assumptions Abstract   PDF   HTML
B. Melosky
Vol 19, No 2 (2012) EGFR tyrosine kinase mutation testing in the treatment of non-small-cell lung cancer Abstract   PDF   HTML
S. Kamel-Reid, G. Chong, D.N. Ionescu, A.M. Magliocco, A. Spatz, M. Tsao, X. Weng, S. Young, T. Zhang, D. Soulieres
Vol 25, No 5 (2018) Elective nodal irradiation or involved-field irradiation in definitive chemoradiotherapy for esophageal squamous cell cancer: a retrospective analysis in clinical N0 patients Abstract   PDF   HTML
Y. Sun, X. L.. Zhang, Q. F. Mao, Y. H. Liu, L. Kong, M.H. Li
Vol 16, No 2 (2009) Electrochemotherapy of tumors Abstract   PDF
Marko Snoj
Vol 18, No 1 (2011) E-Manuscript Article Summaries Details   PDF   HTML
Various Authors
Vol 18, No 2 (2011) E-Manuscript Article Summaries Details   PDF   HTML
Various Authors
Vol 18, No 3 (2011) E-Manuscript Article Summaries Details   PDF   HTML
Various Authors
Vol 18, No 4 (2011) E-manuscript Article Summaries Details   PDF   HTML
Amanda Shand
Vol 18, No 5 (2011) E-manuscript Article Summaries Details   PDF   HTML
Various Authors
Vol 18, No 6 (2011) E-manuscript article summaries Abstract   PDF   HTML
Current Oncology
Vol 19, No 1 (2012) E-manuscript Article Summaries Abstract   PDF   HTML
Multiple Authors
Vol 19, No 2 (2012) E-manuscript article summaries Abstract   PDF   HTML
Various Authors
Vol 26, No 4 (2019) Emerging therapies for the treatment of relapsed or refractory diffuse large B cell lymphoma Abstract   PDF   HTML
P. Skrabek, S. Assouline, A. Christofides, D. MacDonald, A. Prica, R. Sangha, B. A. Matthews, L. H. Sehn
Vol 23, No 6 (2016) Emerging therapies for the treatment of relapsed or refractory follicular lymphoma Abstract   PDF   HTML
D. MacDonald, A. Prica, S. Assouline, A. Christofides, T. Lawrence, L.H. Sehn
Vol 18, No 4 (2011) Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey Abstract   PDF   HTML
S. Verma, L. Provencher, R. Dent
Vol 26, No 4 (2019) Employment outcomes for recent Canadian radiation oncology graduates Abstract   PDF   HTML
S. K. Loewen, R. Halperin, G. Perry, M. Mckenzie, E. Vigneault, T. Stuckless, M. Brundage
Vol 22, No 6 (2015) Enablers and barriers in delivery of a cancer exercise program: the Canadian experience Abstract   PDF   HTML
D. Santa Mina, A. Petrella, K.L. Currie, K. Bietola, S.M.H. Alibhai, J. Trachtenberg, P. Ritvo, A.G. Matthew
Vol 17, No 6 (2010) Encouraging data out of the 2010 Congress of the European Society for Medical Oncology with respect to non-small-cell lung cancer Details   PDF
V. Hirsh
Vol 25, No 4 (2018) Endocrine therapy for breast cancer in the primary care setting Abstract   PDF   HTML
A. Awan, A. Esfahani
Vol 17, No 5 (2010) Endocrine therapy for male breast cancer: rates of toxicity and adherence Abstract   PDF
H. Visram, F. Kanji, S. F. Dent
Vol 20, No 1 (2013) Endocrine therapy for postmenopausal women with hormone receptor–positive her2–negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: a Canadian consensus statement Abstract   PDF   HTML
K.I. Pritchard, K.A. Gelmon, D. Rayson, L. Provencher, Marc Webster, D. McLeod, S. Verma
Vol 17, No 6 (2010) Endometrioid ovarian carcinoma benefits from aromatase inhibitors: case report and literature review Abstract   PDF
Y. Pan, M.S. Kao
Vol 25, No 4 (2018) Engaging cancer patients in clinical practice guideline development: a pilot study Abstract   PDF   Supplemental Material   HTML
M.C. Brouwers, M. Vukmirovic, K. Spithoff, C. Zwaal, S. McNair, N. Peek
Vol 22, No 4 (2015) Enhancing access to cancer care for the Inuit Abstract   PDF   HTML
P. Doering, C. DeGrasse
Vol 26, No 2 (2019) Epidermal growth factor receptor inhibitor–induced hypomagnesemia: a survey of practice patterns among Canadian gastrointestinal medical oncologists Abstract   PDF   HTML
T. Thangarasa, J. Gotfrit, R. A. Goodwin, P. A. Tang, M. Clemons, A. Imbulgoda, M. M. Vickers
Vol 17, No 3 (2010) Epidermal growth factor receptor targeted therapy in stage III and IV head and neck cancer Abstract   PDF
C. Cripps, E. Winquist, M. C. Devries, D. Stys-Norman, R. Gilbert
Vol 25, No 4 (2018) Erratum: Cost-effectiveness of everolimus for the treatment of advanced neuroendocrine tumours of gastrointestinal or lung origin in Canada Abstract   PDF   HTML
A. Chua, A. Perrin, J.F. Ricci, M.P. Neary, M. Thabane
Vol 19, No 3 (2012) Erratum: Legalizing euthanasia or assisted suicide: the illusion of safeguards and controls Details   PDF   HTML
J. Pereira
Vol 21, No 6 (2014) Erratum: Salpingectomy to prevent ovarian cancer Abstract   PDF   HTML
S.A. Narod
Vol 22, No 2 (2015) Erratum: Tumour inflammatory response: adding fuel to the fire? Abstract   PDF   HTML
M. Valdes, M.R. Chasen
Going Beyond Efficacy Erythropoiesis Stimulating Agents: Benefits/Risks in Supportive Care of Cancer Abstract   PDF
Barbara L. Melosky
Vol 22, No 2 (2015) Establishing a clinic-based pancreatic cancer and periampullary tumour research registry in Quebec Abstract   PDF   HTML
A.L. Smith, C. Bascuñana, A. Hall, A. Salman, A.Z. Andrei, A. Volenik, H. Rothenmund, D. Ferland, D. Lamoussenery, A.S. Kamath, R. Amre, D. Caglar, Z.H. Gao, D.G. Haegert, Y. Kanber, R.P. Michel, G. Omeroglu-Altinel, J. Asselah, N. Bouganim, P. Kavan, G. Arena, J. Barkun, P. Chaudhury, S. Gallinger, W.D. Foulkes, A. Omeruglu, P. Metrakos, G. Zogopoulos
Vol 18, No 5 (2011) Establishing a multicentre clinical research network: lessons learned Abstract   PDF   HTML
N. A. Hagen, C. R. Stiles, P. D. Biondo, G. G. Cummings, R. L. Fainsinger, D. E. Moulin, J. L. Pereira, R. Spice
Vol 26, No 2 (2019) Establishing funding rates for colonoscopy and gastroscopy procedures in Ontario Abstract   PDF   HTML   Supplemental Material
J. Monakova, J. Wong, I. Blais, A. Langan, N. Ratansi, D. Morgan, N. N. Baxter
Vol 26, No 2 (2019) Estimating Health Care Costs of Non-Melanoma Skin Cancer in Saskatchewan using Physician Billing Data Abstract   PDF   HTML
D. A. Tran, A. C. Coronado, S. Sarker, R. Alvi
Vol 23, No 3 (2016) Estimating the costs of intensity-modulated and 3-dimensional conformal radiotherapy in Ontario Abstract   PDF   HTML
J.H.E Yong, T. McGowan, R. Redmond-Misner, J. Beca, P. Warde, E. Gutierrez, J.S. Hoch
Vol 17, No 2 (2010) Estimating the national wage loss from cancer in Canada Abstract   PDF
R. B. Hopkins, R. Goeree, C. J. Longo
Vol 23 (2016): Original Cancer Costing Research Using Canadian Data Estimation of drug cost avoidance and pathology cost avoidance through participation in NCIC Clinical Trials Group phase III clinical trials in Canada Abstract   PDF   HTML
P.A. Tang, A.E. Hay, C.J. O’Callaghan, N. Mittmann, C.R. Chambers, J.L. Pater, N.B. Leighl
Mark Bernstein
Vol 22, No 2 (2015) Ethnicity and breast cancer stage at diagnosis: an issue of health equity Abstract   PDF   HTML
A.K. Lofters
Vol 19, No 5 (2012) Evaluating the efficacy of current clinical practice of adjuvant chemotherapy in postmenopausal women with early-stage, estrogen or progesterone receptor–positive, one-to-three positive axillary lymph node, breast cancer Abstract   PDF   HTML
M.B. Hannouf, M. Brackstone, B. Xie, G.S. Zaric
Vol 17, No 4 (2010) Evaluating the impact on quality of life of chemoradiation in gastric cancer Abstract   PDF
Z. Kassam, H. Mackay, C.A. Buckley, S. Fung, M. Pintilie, J. Kim, J. Ringash
Vol 20, No 1 (2013) Evaluation of CancerChatCanada: a program of online support for Canadians affected by cancer Abstract   PDF   HTML
J. Stephen, A. Rojubally, K. MacGregor, D. McLeod, M. Speca, J. Taylor-Brown, K. Fergus, K. Collie, J. Turner, S. Sellick, G. Mackenzie
Vol 17, No 2 (2010) Evaluation of six risk factors for the development of bacteremia in children with cancer and febrile neutropenia Abstract   PDF
J. E. Corral, J. Quezada, E. J. Asturias
Vol 25, No 5 (2018) Evaluation of subcutaneous rituximab administration on Canadian systemic therapy suites Abstract   PDF   HTML
D. A. Stewart, J.S. Boudreault, B. Maturi, D. Boras, R. Foley
Vol 20, No 2 (2013) Evaluation of the clinical benefits of nanoparticle albumin-bound paclitaxel in women with metastatic breast cancer in British Columbia Abstract   PDF   HTML
A.E. Lohmann, C.H. Speers, S.K. Chia
Vol 25, No 4 (2018) Evaluation of the delivery of survivorship care plans for South Asian female breast cancer survivors residing in Canada Abstract   PDF   HTML
S. Singh-Carlson, F. Wong, G. Oshan
Vol 24, No 6 (2017) Evidence in medicine: math versus biology! Abstract   PDF   HTML
T. Younis, M. Thana, C. Skedgel
Vol 25, No 2 (2018) Evidence-based best practices for EGFR T790M testing in lung cancer in Canada Abstract   PDF   HTML
T. Stockley, C.A. Souza, P.K. Cheema, B. Melosky, S. Kamel-Reid, M.S. Tsao, A. Spatz, A. Karsan
Vol 21, No 3 (2014) Evidence-based guidance on venous thromboembolism in patients with solid tumours Abstract   PDF   HTML
M.A. Shea-Budgell, C.M.J. Wu, J.C. Easaw
Vol 21, No 2 (2014) Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with Philadelphia chromosome–positive or BCR-ABL–positive acute lymphoblastic leukemia: a Canadian consensus Abstract   PDF   HTML
S. Couban, L. Savoie, Y. Abou Mourad, B. Leber, M. Minden, R. Turner, V. Palada, N. Shehata, A. Christofides, S. Lachance
Vol 18, No 1 (2011) Evidence-based medicine: an analysis of prophylactic bilateral oophorectomy at time of hysterectomy for benign conditions Details   PDF   HTML
C. A. Larson
Vol 26, No 4 (2019) Evolution of adolescent and young adult oncology in Canada Abstract   PDF   HTML
S. DePauw, C. Rae, B. Schacter, P. Rogers, R. D. Barr
Vol 21, No 1 (2014) Examining cancer-risk profiles for the largest metropolitan areas across Canada Abstract   PDF   HTML
K. DeCaria, R. Rahal, T. Forte, G. Lockwood, J. Xu, H. Bryant, in collaboration with the System Performance Steering Committee and Technical Working Group
Vol 24, No 1 (2017) Examining the medical resource utilization and costs of relapsed and refractory chronic lymphocytic leukemia in Ontario Abstract   PDF   HTML
S. Hassan, S.J. Seung, M. C. Cheung, G. Fraser, B. Kuriakose, C. Trambitas, N. Mittmann
501 - 600 of 1685 Items << < 1 2 3 4 5 6 7 8 9 10 > >>